Back to funds
View filing
HighVista Strategies LLC
hedge fundUpdated 27 days agoManaged by Highvista Strategies Llc • Latest filing Q2 2026
Portfolio value
$438.6M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
48.0%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $122.8M |
| Q2 2023 | $218.6M |
| Q3 2023 | $216.1M |
| Q4 2023 | $275.6M |
| Q1 2024 | $280.4M |
| Q2 2024 | $273.8M |
| Q3 2024 | $290M |
| Q4 2024 | $268.8M |
| Q1 2025 | $259.5M |
| Q2 2025 | $272.1M |
| Q3 2025 | $408M |
| Q4 2025 | $388.3M |
| Q1 2026 | $362.2M |
| Q2 2026 | $438.6M |
Top holdings
147 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | D DBC INVESCO DB COMMDY INDX TRCK | $28.2M | 1.06M | 6.43% | Unchanged |
| 2 | A AAVXF ABIVAX SA | $15.1M | 113.0K | 3.43% | Trimmed(-0.2%) |
| 3 | R RVMDW REVOLUTION MEDICINES INC | $12.5M | 67.0K | 2.86% | Trimmed(-3.4%) |
| 4 | D DFTX DEFINIUM THERAPEUTICS INC | $11.4M | 242.9K | 2.60% | Added(+30.7%) |
| 5 | I IMVT IMMUNOVANT INC | $10.7M | 277.9K | 2.44% | Added(+23.4%) |
| 6 | P PRAX PRAXIS PRECISION MEDICINES I | $10.1M | 30.2K | 2.31% | Added(+14.8%) |
| 7 | R RLAY RELAY THERAPEUTICS INC | $9.5M | 506.2K | 2.16% | Added(+20.0%) |
| 8 | A ALKS ALKERMES PLC | $9.4M | 179.3K | 2.14% | Added(+144.9%) |
| 9 | P PCVX VAXCYTE INC | $8.7M | 149.7K | 1.98% | Added(+20.1%) |
| 10 | T TNGX TANGO THERAPEUTICS INC | $8.1M | 260.1K | 1.85% | Added(+149.6%) |
| 11 | L LQDA LIQUIDIA CORPORATION | $7.8M | 97.9K | 1.78% | Trimmed(-1.9%) |
| 12 | C COGT COGENT BIOSCIENCES INC | $7.3M | 188.8K | 1.67% | Trimmed(-4.2%) |
| 13 | G GPCR STRUCTURE THERAPEUTICS INC | $7M | 130.8K | 1.60% | Added(+5.5%) |
| 14 | E ELVN ENLIVEN THERAPEUTICS INC | $7M | 137.9K | 1.60% | Added(+88.6%) |
| 15 | A AMLX AMYLYX PHARMACEUTICALS INC | $6.9M | 386.1K | 1.58% | Added(+9.7%) |
| 16 | S SYRE SPYRE THERAPEUTICS INC | $6.9M | 77.8K | 1.57% | Trimmed(-46.8%) |
| 17 | L LBRX LB PHARMACEUTICALS INC | $6.9M | 211.5K | 1.57% | Added(+21.8%) |
| 18 | C CYTK CYTOKINETICS INC | $6.6M | 78.0K | 1.52% | Added(+33.0%) |
| 19 | B BEPC C4 THERAPEUTICS INC | $6.3M | 1.35M | 1.44% | — |
| 20 | T TYRA TYRA BIOSCIENCES INC | $5.9M | 184.8K | 1.35% | Added(+40.7%) |